1. Limited utility of plasma elafin as a biomarker for skin graft‐versus‐host disease following allogeneic stem cell transplantation. (16th July 2021) Authors: George, L.; Mahabal, G.; Mohanan, E.; Balasubramanian, P.; Peter, D.; Pulimood, S.; Lakshmi, K.; Jeyaseelan, L.; Abraham, A.; Srivastava, A.; Mathews, V.; George, B. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 8(2021) Page Start: 1482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Limited utility of plasma elafin as a biomarker for skin graft‐versus‐host disease following allogeneic stem cell transplantation. (1st December 2021) Authors: George, L.; Mahabal, G.; Mohanan, E.; Balasubramanian, P.; Peter, D.; Pulimood, S.; Lakshmi, K.; Jeyaseelan, L.; Abraham, A.; Srivastava, A.; Mathews, V.; George, B. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 8(2021) Page Start: 1482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗